BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9627114)

  • 1. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
    Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p22/PACAP response gene 1 (PRG1): a putative target gene for the tumor suppressor p53.
    Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
    Ann N Y Acad Sci; 1998 Dec; 865():27-36. PubMed ID: 9927993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo.
    Schäfer H; Arlt A; Trauzold A; Hünermann-Jansen A; Schmidt WE
    Biochem Biophys Res Commun; 1999 Aug; 262(1):139-45. PubMed ID: 10448082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line.
    Schäfer H; Trauzold A; Siegel EG; Fölsch UR; Schmidt WE
    Cancer Res; 1996 Jun; 56(11):2641-8. PubMed ID: 8653710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K; Ehinger M; Svedberg H; Gullberg U
    Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
    Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
    Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis.
    Sadasivam S; Gupta S; Radha V; Batta K; Kundu TK; Swarup G
    Oncogene; 2005 Jan; 24(4):627-36. PubMed ID: 15580302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.
    Schäfer H; Diebel J; Arlt A; Trauzold A; Schmidt WE
    FEBS Lett; 1998 Oct; 436(2):139-43. PubMed ID: 9781666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
    Tarunina M; Grimaldi M; Ruaro E; Pavlenko M; Schneider C; Jenkins JR
    Oncogene; 1996 Aug; 13(3):589-98. PubMed ID: 8760300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
    Akashi M; Osawa Y; Koeffler HP; Hachiya M
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):607-16. PubMed ID: 9895308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y; Tan M; Gosink M; Wang KK; Sun Y
    Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
    Li C; Lin M; Liu J
    Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of p53 by Pitx1.
    Liu DX; Lobie PE
    Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
    Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
    Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M
    Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.